Cierra N. Sharp

Cierra N. Sharp

Jun 14, 2016

Group 6 Copy 18
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Probiotics for plants? Fighting insects by boosting corn immune systems

    Beneficial soil microorganisms can boost the plant immune system. We want to know if farming practices that...

    Can we stop amphibian extinction by increasing immunity to the frog chytrid fungus?

    As a result of the arrival of the chytrid fungus in Australia, corroboree frog populations declined so now...

    Creating a Genetic Circuit Control Toolbox

    Synthetic biology studies the design of genetic circuits to program cells to solve problems in areas like...

    Backer Badge Funded